Suppr超能文献

高血压管理在慢性肾病:NPs 的指南。

Hypertension management in chronic kidney disease: A guide for NPs.

出版信息

Nurse Pract. 2024 Jul 1;49(7):13-20. doi: 10.1097/01.NPR.0000000000000201. Epub 2024 Jun 25.

Abstract

This article offers a guide for NPs for managing hypertension (HTN) in adults in the setting of chronic kidney disease (CKD). It outlines evidence-based strategies, including lifestyle modifications, pharmacologic interventions, and patient education measures, that can be used in patients with CKD to optimize BP control. Special considerations, such as comorbid mental health conditions and individualized treatment plans, are also addressed. NPs play a pivotal role in improving outcomes by fostering patient engagement and adherence. By embracing this holistic approach, NPs are poised to enhance the quality of care and well-being of patients with CKD and HTN.

摘要

本文为初级保健护士(NPs)提供了在慢性肾脏病(CKD)背景下管理成人高血压(HTN)的指南。它概述了循证策略,包括生活方式改变、药物干预和患者教育措施,可用于 CKD 患者以优化血压控制。还讨论了特殊注意事项,如合并心理健康状况和个体化治疗计划。NPs 通过促进患者的参与和依从性,在改善结局方面发挥着关键作用。通过采用这种整体方法,NPs 有望提高 CKD 和 HTN 患者的护理质量和幸福感。

相似文献

1
Hypertension management in chronic kidney disease: A guide for NPs.
Nurse Pract. 2024 Jul 1;49(7):13-20. doi: 10.1097/01.NPR.0000000000000201. Epub 2024 Jun 25.
2
Management of urinary stones by experts in stone disease (ESD 2025).
Arch Ital Urol Androl. 2025 Jun 30;97(2):14085. doi: 10.4081/aiua.2025.14085.
3
Design considerations for future renoprotection trials in the era of multiple therapies for chronic kidney disease.
Nephrol Dial Transplant. 2025 Feb 5;40(Supplement_1):i70-i79. doi: 10.1093/ndt/gfae210.
5
Synbiotics, prebiotics and probiotics for people with chronic kidney disease.
Cochrane Database Syst Rev. 2023 Oct 23;10(10):CD013631. doi: 10.1002/14651858.CD013631.pub2.
6
Non-medical prescribing versus medical prescribing for acute and chronic disease management in primary and secondary care.
Cochrane Database Syst Rev. 2016 Nov 22;11(11):CD011227. doi: 10.1002/14651858.CD011227.pub2.
7
Interventions for patients and caregivers to improve knowledge of sickle cell disease and recognition of its related complications.
Cochrane Database Syst Rev. 2016 Oct 6;10(10):CD011175. doi: 10.1002/14651858.CD011175.pub2.
8
Intensive Home Blood Pressure Lowering in Patients With Advanced CKD.
Am J Kidney Dis. 2025 Mar;85(3):320-328. doi: 10.1053/j.ajkd.2024.08.010. Epub 2024 Oct 18.
9
EORTC guidelines for the use of erythropoietic proteins in anaemic patients with cancer: 2006 update.
Eur J Cancer. 2007 Jan;43(2):258-70. doi: 10.1016/j.ejca.2006.10.014. Epub 2006 Dec 19.

本文引用的文献

1
KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease.
Kidney Int. 2024 Apr;105(4S):S117-S314. doi: 10.1016/j.kint.2023.10.018.
2
General Anxiety Disorder and Primary Hypertension: Is There a Link?
J Nerv Ment Dis. 2023 Jul 1;211(7):525-529. doi: 10.1097/NMD.0000000000001650. Epub 2023 Mar 15.
4
Hypertension Management in Patients with Chronic Kidney Disease.
Methodist Debakey Cardiovasc J. 2022 Sep 6;18(4):41-49. doi: 10.14797/mdcvj.1119. eCollection 2022.
5
Etiopathogenesis of kidney disease in minority populations and an updated special focus on treatment in diabetes and hypertension.
J Natl Med Assoc. 2022 Jun;114(3S2):S3-S9. doi: 10.1016/j.jnma.2022.05.004. Epub 2022 May 17.
6
Chlorthalidone for Hypertension in Advanced Chronic Kidney Disease.
N Engl J Med. 2021 Dec 30;385(27):2507-2519. doi: 10.1056/NEJMoa2110730. Epub 2021 Nov 5.
7
Renin Angiotensin Aldosterone System Inhibitors in Chronic Kidney Disease: A Difficult Equation.
Am J Cardiovasc Drugs. 2021 Nov;21(6):619-627. doi: 10.1007/s40256-021-00467-9. Epub 2021 Mar 23.
8
9
Management of Obesity in Adults with CKD.
J Am Soc Nephrol. 2021 Apr;32(4):777-790. doi: 10.1681/ASN.2020101472. Epub 2021 Feb 18.
10
Dapagliflozin in Patients with Chronic Kidney Disease.
N Engl J Med. 2020 Oct 8;383(15):1436-1446. doi: 10.1056/NEJMoa2024816. Epub 2020 Sep 24.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验